Revelation Biosciences Inc. (REVBW) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Revelation Biosciences In...

NASDAQ: REVBW · Real-Time Price · USD
0.01
-0.00 (-10.71%)
At close: Jun 09, 2025, 2:31 PM

Revelation Biosciences Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-23.39M -24.02M -24.5M -15.9M -8.96M -120.25K 875.06K 2.33M 1.95M -10.83M -13.48M -15.36M -15.99M -11.99M -11.02M -8.14M -5.67M
Depreciation & Amortization
42.36K 41.41K 40.45K 26.01K 25.05K 25.05K 25.05K 25.05K 25.05K 25.05K 25.05K 24.86K 22.4K 16.78K 10.52K 4.45K 642.00
Stock-Based Compensation
424.4K 233.04K 217.57K 153.38K 155.72K 155.72K 155.99K 164.57K 195.32K 301.12K 374.67K 465.31K 506.44K 470.88K 408.81K 277.49K 146.17K
Other Working Capital
3.41M 2.96M 2.92M 6.63M -19.18K 232.47K 182.58K -597.19K -1.63M -64.93K 1.07M 1.76M 2.1M 625.86K -319.53K -918.59K 178.35K
Other Non-Cash Items
-1.31M -1.65M -1.73M 39.98K -850.72K -8.25M -8.91M -8.38M -7.31M 449.62K 1.18M 691.03K 58.01K 52.38K 1.15M 1.24M 1.22M
Deferred Income Tax
n/a n/a -15.89K -78.86K -78.86K -78.86K 653.05K 212.42K -434.66K -434.66K -1.15M -647.08K n/a n/a n/a n/a n/a
Change in Working Capital
2.44M 2.31M 4.64M 6.92M 883.44K 982.13K 973.72K -599.8K -2.39M -730.97K -97.81K 1.17M 1.87M 356.22K -154.33K -877.44K 397.11K
Operating Cash Flow
-23.24M -23.28M -21.54M -9.04M -8.55M -7.29M -6.23M -6.25M -7.96M -11.22M -13.15M -13.65M -13.54M -11.09M -9.6M -7.5M -3.91M
Capital Expenditures
-19.17K -38.34K -56.03K -38.34K -19.17K n/a n/a n/a n/a n/a 16.15K 16.15K -32.86K -131.96K -148.12K -148.12K -99.1K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -482.87K -482.87K -482.87K -482.87K n/a n/a n/a
Sales Maturities Of Investments
-281.97K -281.97K -281.97K -281.97K n/a n/a n/a n/a n/a n/a 525.29K 807.25K 878.83K 1.01M 488.18K 206.22K 134.64K
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -525.29K -525.29K -525.29K -525.29K n/a n/a n/a
Investing Cash Flow
-301.14K -320.31K -338K -320.31K -19.17K n/a n/a n/a n/a n/a 16.15K 298.12K 249.1K 150K 133.85K -148.12K -99.1K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a -796.88K -796.88K -796.88K -796.88K n/a -275K -275K -275K
Common Stock Repurchased
n/a n/a 5K 5K 5K n/a -5K -5K -5K -7.65M -33.35M -33.35M -33.35M -25.7M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
9.13M 9.13M 23.16M 19.42M 14.03M 14.03M 34.00 34.00 19.00 4.28M 4.28M 4.28M 4.28M n/a -3.15M -2.15M -2.15M
Financial Cash Flow
12.85M 18.26M 14.58M 10.83M 5.42M 14.03M 14.03M 18.48M 18.48M 15.2M -9.73M -14.18M -14.18M -16.92M 15.87M 16.87M 16.87M
Net Cash Flow
-10.85M -5.49M -7.45M -3.64M -3.15M 6.74M 7.8M 12.24M 10.52M 3.98M 2.06M -2.9M -2.83M -3.22M 6.12M 9.23M 12.87M
Free Cash Flow
-23.28M -23.34M -21.61M -9.07M -8.57M -7.29M -6.23M -6.25M -7.96M -11.22M -13.13M -13.64M -13.57M -11.22M -9.75M -7.65M -4M